Advertisement

Topics

Companies Related to "Prostate Cancer Patients OncBioMune Phase Clinical Trial ProscaVax" [Most Relevant Company Matches] - Page: 20 RSS

07:37 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Prostate Cancer Patients OncBioMune Phase Clinical Trial ProscaVax" found in our extensive corporate database of over 50,000 company records.

Showing "Prostate Cancer Patients OncBioMune Phase Clinical Trial ProscaVax" Companies 476–500 of 9,500+

Relevant

ImmunoCellular Therapeutics, Ltd. and BioWa, Inc.

IMUC is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently started a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor associated antigens for newly diagnosed glioblastoma. To learn more about IMU...


Geovax Labs

GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining r...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...


Tower Hematology Oncology Medical Group

Tower Hematology Oncology Medical Group was formed in 1991 as the result of a merger between two well-established medical oncology practices that had served patients in Los Angeles for more than 10 years. We are a group of diverse cancer specialists that focus on the full spectrum of oncology and hematology problems. By pooling our knowledge, we are able to provide a strong research-based practic...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders. We have five product candidates in clinical trials addressing therapeutic indications with significant unmet needs. Our product candidate for insomnia is currently in Phase III clinical trials and o...

Allied Research International Inc

Allied Research International Inc. (formerly known as Allied Clinical Research) is a dynamic group of scientific and medical professionals dedicated to the advancement of clinical research. For over ten years, Allied Research International (ARI) has been providing services to Pharmaceutical and Biotechnology industries. These services range from conducting complex single site Phase I / Bioequivale...

DSG Inc.

DSG Inc. supports clinical trial data collection and management with innovative technology solutions including Electronic Data Capture with specialized Clinical Data Management services, Electronic Patient Diaries, Clinical Trial Management Systems and digital on-demand Case Report Form publishing management software. DSG’s products allow user-friendl...

Parallel 6

Parallel 6, an innovator in enterprise cloud-based technologies, enables customer engagement and real-time data insights. Clinical Reach, a Parallel 6 product, enables clinical trial stakeholders to digitally recruit, eQualify, eConsent and engage clinical trial participants through their patented platform. Additional solutions include GovReach fo...

PharmaNet Development Group

PharmaNet Development Group, a global, drug development services company, provides expertise to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet companies offer clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical develop...

Trophogen, Inc.

Trophogen, Inc. is a U.S.-based biotechnology company founded in 2001 with Series A funding from Toucan Capital, in late stage preclinical focusing on development of human and bovine high affinity glycoprotein hormone and related growth factor superagonist analogs which are long-acting, more potent and efficacious, for human infertility, animal superovulat...

AndroScience Corporation

Founded in 2000, AndroScience Corporation (ASC) is developing two novel small molecule platforms based on the therapeutic targets of the androgen receptor (AR) and select members of the Signal Transducer and Activator of Transcription (STAT) signaling pathway. The first patented family of compounds function through the enhancing degradation of AR protein, a novel mechanism of action described as A...

Insight Genetics

Insight Genetics is a molecular diagnostics company focused on enhancing personalized cancer care. The company’s companion diagnostics detect specific cancer biomarkers related to therapeutics that are currently in development or on the market. Insight partners with leading academic researchers, pharmaceutical and biotechnology companies, clinical ref...

Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc.

Nivalis Therapeutics, Inc. (http://www.nivalis.com) is a pharmaceutical company that has historically been focused on the discovery and development of product candidates for patients with cystic fibrosis, or CF. The Company’s development candidates selectively target an enzyme known as S-nitrosoglutathione reductase (GSNOR). GSNOR regulates levels of ...

National Breast Cancer Awareness Month

In the United States, an estimated 192,370 women and 1,910 men will be diagnosed with new cases of breast cancer in 2009. Breast cancer ranks second as a cause of cancer death in women (after lung cancer). Death rates for breast cancer have steadily decreased in women since 1990, due to progress in both earlier detection and improved treatment. The current five-year survival rate for female breast...

Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...

Oncogene Research projects

Today, OncogeneScience® based in Cambridge MA (at the original Applied bioTechnology facility) develops, manufactures, and markets high quality, ready-to-use cancer reagent systems to commercial and clinical research customers worldwide to further establish the clinical utility of these microtiter assays. Its core competencies include unparalleled microtiter plate assay expertise and a significan...

Cell Therapeutics, Inc.

As CTI's cancer drugs progress through clinical trials to commercialization, our commitment to patients and the real issues of their cancer treatments grows stronger. The challenge to overcome the therapeutic limitations of cancer treatment provides us with a focus and sense of urgency. Targeting the Side Effects and Toxicities of Conventional Cancer Therapies The American Cancer Society report...

Clinical Ink

Founded in 2007, Clinical Ink is dedicated to transforming clinical development - from Start to Submit™ - by creating a completely ‘paperless’ clinical trial platform. Clinical Ink’s SureSource platform is purpose-built to capture source data and documents electronically for sites, subjects, sponsors, and CROs. Clinical Ink maintains offices i...

Catalyst Pharmaceutical Research (CPR)

Catalyst Pharmaceutical Research (CPR) is an integrated clinical research organization providing high-quality clinical research, biostatistics and data processing, regulatory, and licensing services support for pharmaceutical development. CPR's experienced staff applies industry proven information technology systems for rapid and reliable trial management, and electronic data capture and analysis,...

MVI

Wisconsin-based MVI is developing two plasmid DNA vaccines to treat men with prostate cancer. MVI has licensed patented technologies that were developed in the laboratory of Dr. Douglas McNeel at the University of Wisconsin-Madison. More information is available at www.madisonvaccines.com.

GeneSegues

GeneSegues is a biopharmaceutical company built upon advanced, targeted drug delivery technology. We conduct research and early-stage development of proprietary oncology biopharmaceuticals using our ligand-directed, nanoencapsulation technology. Our two initial product candidates are antisense therapeutics for treatment of advanced head neck and prostate cancers. We are currently conducting animal...

Cubist Pharmaceuticals

Cubist Pharmaceuticals Incorporated is a drug company focused on the discovery, development and commercialization of novel drugs to treat infections. Daptomycin, the Company's in-licensed lead product, is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections. Cubist Pharmaceuticals began Phase III cli...

BioLineRx Ltd. and Compugen Ltd.

BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. BioLineRx’s current portfolio consists of five clinical stage candidates: BL-1020 for schizophrenia has commenced a Phase II/III study; BL-1040 for...

BiomarkerBase

BiomarkerBase™ (http://www.biomarkerbase.com) includes every molecular biomarker on a drug label, every biomarker in a PMA-approved diagnostic, prognostic, or companion diagnostic (theranostic) test, and every biomarker in an active phase 3 or 4 clinical drug trial. All records in BiomarkerBase™ are linked directly to primary authorities such as ...

Rebiotix Inc.

Rebiotix Inc, which is part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionize the treatment of debilitating diseases. Rebiotix possesses a deep and diverse clinical pipeline, with its lead drug candidate, RBX2660, in Phase 3 clinical development for th...


More From BioPortfolio on "Prostate Cancer Patients OncBioMune Phase Clinical Trial ProscaVax"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks